ESOT - European Society for Organ Transplantation - has a wealth of information for patients and professionals.
Our COMPARE trial has reached its 12-month follow-up end point. Data clean-up and analysis are underway, with trial results due by September 2018.
The COPE Consortium is funded through the EU's 7th Framework Programme on research, technological development and demonstration and is the official organ preservation task force of the European Society for Organ Transplantation (ESOT). The Consortium brings together academic institutions, clinical and scientific experts and small and medium sized enterprises from across Europe to work together on advancing organ preservation techniques.
The COPE Consortium aims to advance and develop organ preservation technologies by performing clinical and translational studies with on-going experimental refinement. Through testing quality and safety, increasing the efficiency and refining preservation strategies we set out to bring technologies from the bench to the bedside.
Focusing on three clinical trials and two experimental work programmes across Europe the Consortium is working on improving preservation and reconditioning strategies for kidneys and livers procured for transplantation. By exploiting collaborations between industry and academic institutions we aim to introduce organ preservation technologies that will increase the number and quality of grafts used for transplantation.